Paper6537802
Increased tissue deposition and decreased excretion of platinum following administration of cisplatin to cisplatin-pretreated animals.
Litterst CL and 1 other. Cancer Chemother Pharmacol, 1984. Cited by 27 papers, by iCite.
Cite this record
ConductScience Library. Increased tissue deposition and decreased excretion of platinum following administration of cisplatin to cisplatin-pretreated animals. Papers, record 6537802. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/6537802
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Increased tissue deposition and decreased excretion of platinum following administration of cisplatin to cisplatin-pretreated animals.
- PubMed
Topics9
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Cisplatin | Major topic |
| Platinum | Major topic |
| Animals | |
| Female | |
| Guinea Pigs | |
| Kidney | |
| Male | |
| Rabbits | |
| Tissue Distribution |
Source PubMed
References9
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 6241789 | Cisplatinum: a review, with special reference to cellular and molecular interactions. | Agents Actions | 1984 | https://conductscience.org/library/papers/6241789 | PubMed |
| 2 | 4278921 | The preparation of red cell ghosts (membranes). | Methods Enzymol | 1974 | https://conductscience.org/library/papers/4278921 | PubMed |
| 3 | 657154 | Acute renal failure after cis-dichlorodiammineplatinum(II) and gentamicin-cephalothin therapies. | Cancer Treat Rep | 1978 | https://conductscience.org/library/papers/657154 | PubMed |
| 4 | 6422414 | Ototoxic and nephrotoxic effects of combined treatment with cis-diamminedichloroplatinum and kanamycin in the guinea pig. | Otolaryngol Head Neck Surg | 1984 | https://conductscience.org/library/papers/6422414 | PubMed |
| 5 | 966327 | Influence of certain metals on the level of metallothionein-like proteins in the liver and kidneys of rats. | J Toxicol Environ Health | 1976 | https://conductscience.org/library/papers/966327 | PubMed |
| 6 | 1277140 | Distribution and disposition of platinum following intravenous administration of cis-diamminedichloroplatinum(II) (NSC 119875) to dogs. | Cancer Res | 1976 | https://conductscience.org/library/papers/1277140 | PubMed |
| 7 | 907657 | Analysis of platinum in biological materials by flameless atomic absorption spectrophotometry. | Biochem Med | 1977 | https://conductscience.org/library/papers/907657 | PubMed |
| 8 | 4831228 | Equine hepatic and renal metallothioneins. Purification, molecular weight, amino acid composition, and metal content. | J Biol Chem | 1974 | https://conductscience.org/library/papers/4831228 | PubMed |
| 9 | 4459127 | Studies on metal-binding proteins of low molecular weight from renal tissue of rabbits exposed to cadmium or mercury. | Environ Physiol Biochem | 1974 | https://conductscience.org/library/papers/4459127 | PubMed |
Cited by9
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 27 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 20227292 | Shape changes induced by N-terminal platination of ubiquitin by cisplatin. | J Am Soc Mass Spectrom | 2010 | https://conductscience.org/library/papers/20227292 | PubMed |
| 8174197 | Factors affecting human autopsy kidney-cortex and kidney-medulla platinum concentrations after cisplatin administration. | Cancer Chemother Pharmacol | 1994 | https://conductscience.org/library/papers/8174197 | PubMed |
| 7706473 | Cisplatin-associated anemia: an erythropoietin deficiency syndrome. | J Clin Invest | 1995 | https://conductscience.org/library/papers/7706473 | PubMed |
| 7497604 | Long-term pharmacokinetic behavior of platinum after cisplatin administration. | Cancer Chemother Pharmacol | 1995 | https://conductscience.org/library/papers/7497604 | PubMed |
| 6428763 | Effects of the diuretics mannitol or acetazolamide on nephrotoxicity and physiological disposition of cisplatin in rats. | Cancer Chemother Pharmacol | 1984 | https://conductscience.org/library/papers/6428763 | PubMed |
| 6241789 | Cisplatinum: a review, with special reference to cellular and molecular interactions. | Agents Actions | 1984 | https://conductscience.org/library/papers/6241789 | PubMed |
| 3390078 | Correlations between cis-platinum dosage and toxicity in a guinea pig model. | Arch Otorhinolaryngol | 1988 | https://conductscience.org/library/papers/3390078 | PubMed |
| 2990752 | The effect of cisplatin on renal ATPase activity in vivo and in vitro. | Cancer Chemother Pharmacol | 1985 | https://conductscience.org/library/papers/2990752 | PubMed |
| 1931468 | Disposition and tumour concentrations of platinum in hypoalbuminaemic patients after treatment with cisplatin for cancer of the head and neck. | Br J Clin Pharmacol | 1991 | https://conductscience.org/library/papers/1931468 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/6537802
GET https://conductscience.org/api/papers/v1/6537802/authors